story of the week
Cobimetinib Plus Atezolizumab in BRAFV600 Wild-Type Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cobimetinib Plus Atezolizumab in BRAFV600 Wild-Type Melanoma: Primary Results From the Randomized Phase 3 IMspire170 Study
Ann. Oncol 2020 Dec 10;[EPub Ahead of Print], H Gogas, B Dréno, J Larkin, L Demidov, D Stroyakovskiy, Z Eroglu, PF Ferrucci, J Pigozzo, P Rutkowski, J Mackiewicz, I Rooney, A Voulgari, S Troutman, B Pitcher, Y Guo, Y Yan, M Castro, S Mulla, K Flaherty, A AranceFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.